The HSP70-fused foot-and-mouth disease epitope elicits cellular and humoral immunity and drives broad-spectrum protective efficacy
Abstract Current foot-and-mouth disease (FMD) vaccines have significant limitations, including side effects due to oil emulsions at the vaccination site, a narrow spectrum of protective efficacy, and incomplete host defenses mediated by humoral immunity alone. To overcome these limitations, new FMD...
Guardado en:
Autores principales: | Hyundong Jo, Bong Yoon Kim, So Hui Park, Hyun Mi Kim, Sung Ho Shin, Seong Yun Hwang, Su-Mi Kim, Byounghan Kim, Jong-Hyeon Park, Min Ja Lee |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/50c9f0036e8f4059bec7794308175e25 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CLEC14a-HSP70-1A interaction regulates HSP70-1A-induced angiogenesis
por: Jihye Jang, et al.
Publicado: (2017) -
Validation of Pretreatment Methods for the In-Process Quantification of Foot-and-Mouth Disease Vaccine Antigens
por: Ah-Young Kim, et al.
Publicado: (2021) -
ARD1-mediated Hsp70 acetylation balances stress-induced protein refolding and degradation
por: Ji Hae Seo, et al.
Publicado: (2016) -
Evaluation and use of in-silico structure-based epitope prediction with foot-and-mouth disease virus.
por: Daryl W Borley, et al.
Publicado: (2013) -
Anti-leukemia activity of a Hsp70 inhibitor and its hybrid molecules
por: Seong-Hyun Park, et al.
Publicado: (2017)